Akèy › Anplwayè › Keros Therapeutics
Keros Therapeutics: Salè H-1B ak pajon
Keros Therapeutics depoze 5 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 5. Medyèn salè yo ofri a: $180,000.
Èske Keros Therapeutics pajone visa H-1B?
Keros Therapeutics depoze 5 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou May 1, 2025. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Associate Director, Statistical Programming | 2 | $180,000 |
| Scientist, In Vivo | 1 | $130,000 |
| Vice President of Pharmacovigilance | 1 | $300,000 |
| Research Scientist/Research Associate II | 1 | $83,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 1 | $130,000 |
| FY2024 | 2 | $180,000 |
| FY2025 | 2 | $191,500 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Research Scientist/Research Associate II | $83,000–$89,000 Nivo I | Lexington, MA | May 1, 2025 | Oct 1, 2025 | Certifye |
| Vice President of Pharmacovigilance | $300,000–$400,000 Nivo IV | Lexington, MA | Feb 18, 2025 | Feb 20, 2025 | Certifye |
| Associate Director, Statistical Programming | $180,000–$190,000 Nivo III | Piscataway, NJ | Jan 23, 2024 | Feb 26, 2024 | Certifye |
| Associate Director, Statistical Programming | $180,000–$190,000 Nivo III | Piscataway, NJ | Dec 12, 2023 | Feb 12, 2024 | Certifye |
| Scientist, In Vivo | $130,000–$140,000 Nivo I | Lexington, MA | May 3, 2023 | Oct 1, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).